FDA approves new blood test for Alzheimer’s disease - The Hill

The FDA has authorized a new blood test developed by Roche and Eli Lilly that can detect biomarkers associated with Alzheimer's disease. This marks the first FDA approval for such a diagnostic blood test, offering a potentially less invasive alternative to current detection methods like spinal taps or brain scans. The test could help identify Alzheimer's earlier and more conveniently for patients and healthcare providers.